Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-22T15:36:44.895Z Has data issue: false hasContentIssue false
  • English
  • Français

Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers

Published online by Cambridge University Press:  19 October 2009

N. Yamane ,
Y. Nakamura ,
M. Yuki ,
T. Odagiri  and
N. Ishida
N. Yamane
Affiliation:
Clinical Microbiology Branch, Central Clinical Laboratory, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980, Japan
Y. Nakamura
Affiliation:
Clinical Microbiology Branch, Central Clinical Laboratory, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980, Japan
M. Yuki
Affiliation:
Clinical Microbiology Branch, Central Clinical Laboratory, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980, Japan
T. Odagiri
Affiliation:
Department of Bacteriology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Sendai 980, Japan
N. Ishida
Affiliation:
Department of Bacteriology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Sendai 980, Japan
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A cold-adapted influenza A virus, CR-37 (H1N1), derived from genetic reassortment between A/Ann Arbor/6/60 (H2N2) cold-adapted variant virus and A/California/10/78 (H1N1) wild-type virus, was tested in Japanese adult volunteers. The CR-37 live virus preparation induced only low-grade clinical reactionsin volunteers for the first 3–4 days after inoculation. Two vaccinees who did not show any antibody changes became febrile (over 38–0 °C). Skin tests using the vaccine preparation and uninfected allantoic fluid were performed, and indicated that one of these two vaccinees was positive for the CR-37 vaccine preparation. A high proportion of the vaccinees whose sera had a haemagglutination-inhibition (HI) antibody titre against thevaccine strain of ≤ 64 before inoculation, seroconverted in both HI and neuraminidase-inhibition (NA1) antibody titrations, and only a few seroconverted in the titration of antibody against type-specific internal antigens. The serological examinations against heterotypic H1N1 variants indicated that the cold-adapted live influenza virus vaccine could induce a broad spectrum of HI antibody reactivity and immunity of long duration.

Type
Research Article
Information
Journal of Hygiene , Volume 92 , Issue 2 , April 1984 , pp. 231 - 242
Copyright
Copyright © Cambridge University Press 1984

References

REFERENCES

Chanock, R. M. & Murphy, B. R. (1980). Use of temperature-sensitive and cold-adapted mutant viruses in immunoprophylaxis of acute respiratory tract disease. Review of Infectious Diseases 2, 421.CrossRefGoogle ScholarPubMed
Lazar, A., Okabe, N. & Wright, P. F. (1980). Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H INI) recombinant virus. Injection and Immunity 27, 862.CrossRefGoogle Scholar
Lerman, S. J., Wright, P. F. & Path, K. D. (1980). Antibody decline in children following A/New Jersey/76 influenza virus immunization. Journal of Pediatrics 96, 271.CrossRefGoogle ScholarPubMed
Maassab, H. F. (1967). Adaptation andgrowth characteristics of influenza virus at 25 °C. Nature (London) 213, 612.CrossRefGoogle Scholar
Maassab, H. F., Cox, N. J., Murphy, B. R. & Kendal, A. P. (1977). Biological, genetic and biochemical characterization of a cold-adapted recombinant A/Victoria/3/75 virus and its evaluation in volunteers. Developments in Biological Standardization 39, 25.Google ScholarPubMed
Maassab, H. F., Francis, T. Jr, Davenport, F. M., Hennessy, A. V., Minuse, E. & Anderson, G. (1969). Laboratory and clinical characteristics of attenuated strains of influenza virus. Bulletin of the World Health Organization 41, 589.Google ScholarPubMed
Maassab, H. F., Kendal, A. P., Abrams, G. D. & Monto, A. S. (1982). Evaluation of a cold-recombinant influenza virus vaccine in ferrets. Journal of Infectious Diseases 146, 780.CrossRefGoogle ScholarPubMed
Moritz, A. J., Kunz, C., Hofman, H., Lierl, E., Reeve, P. & Maassab, H. F. (1980). Studies of a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers. Journal of Infectious Diseases 142, 857.CrossRefGoogle Scholar
Murphy, B. R., Chanock, R. M., Clements, M. L., Anthony, W. C., Seal, A. J., Cisneros, L. A., Rennels, M. B., Miller, E. H., Black, R. E., Levine, M. M., Betts, R. F., Douglas, R. G. Jr, Maassab, H. F., Cox, N. J. & Kendal, A. P. (1981). Evaluation of A/Alaska/6/77 (H3N2) cold-adapted donor viruses in adult seronegativevolunteers. Infection and Immunity 32, 693.CrossRefGoogle Scholar
Murphy, B. R., Holley, H. P. Jr, Berquist, E. J., Levine, M. M., Spring, S. B., Maassab, H. F., Kendal, A. P.& Chanock, R. M. (1979). Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Infection and Immunity 23, 253.CrossRefGoogle Scholar
Murphy, R. R., Nelson, D. L., Wright, P. F., Tierney, E. L., Phelan, M. A. & Chanock, R. M.. (1982). Secretory andsystemic immunological response in children infected with live attenuated influenza A virus vaccine. Infection and Immunity 36, 1102.CrossRefGoogle Scholar
Murphy, B. R., Rennels, M. B., Douglas, R. G. Jr, Betts, R. F., Couch, R. B., Cate, T. R. Jr, Ciianock, R. M., Kendal, A. P., Maassaii, H. F., Suwanagool, S., Sotman, S. B., Cisnekos, L. A., Anthony, W. C., Nalin, D. R. & Levine, M. M. (1980). Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-lA2 and cold-adapted recomhinant viruses in Rcroncgativo adult volunteers. Infection and Immunity 29, 348.CrossRefGoogle ScholarPubMed
Odagiri, T., DeBorde, D. C. & Maassah, H. F. (1982). Cold-adapted recombinants of influenza A virus in MDCK cells. 1. Development and characterization of A/Ann Arbor/6/60 x A/ Alaska/0/77 rccombinant viruses. Virology 119, 82.CrossRefGoogle Scholar
Palmer, D. F., Coleman, M. T., Dowdle, W. R. & Schild, G. C.. (1975). Advanced Laboratory Technique for Influenza Diagnosis. U.S. Department of Health, Education and Welfare, Immunology Series, no. 6.Google Scholar
Reeve, P.Batia Gerendas, Moritz A., Liehl, E., Kunz, C., Hofmann, H. & Maassah, H. F. (1980). Studies in man with cold-recombinant influenza virus (H1N1) livevaccine. Journal of Medical Virology 6, 75.CrossRefGoogle Scholar
Wright, P. F., Okabe, N., McKee, K. T. Jr, Maassab, H. F. & Karzon, D. T. (1982). Cold-adapted recombinant influenza A virus vaccine in seronegative young children. Journal of Infectious Diseases 146, 71.CrossRefGoogle ScholarPubMed
Wright, P. F., Ross, K. B., Thompson, J. & Karzon, D. T. (1977). Influenza A infections in young children: primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. New England Journal of Medicine 296, 829.CrossRefGoogle ScholarPubMed
Yamane, N., Hiratsuka, M., Arikawa, J., Odagiri, T. & Ishida, N. (1981). Antibody responses after repeated influenza A virus immunizations among schoolchildren in Japan. Journal of Hygiene 87, 383.CrossRefGoogle ScholarPubMed
Yamane, N., Yuki, M. & Nakamura, Y. (1983). Single radial complement fixationtest for assaying antibody to influenza virus type-specific antigens. Journal of Clinical Microbiology 18, 837.CrossRefGoogle Scholar